Jun-Chi Xu

Prof. Jun-Chi Xu

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
RQRui Qiang
Rui Qiang
XLXing-Zi Liu
Xing-Zi Liu
JXJun-Chi Xu
Jun-Chi Xu
Acute-on-chronic liver failure (ACLF) is a group of clinical syndromes related to severe acute liver function impairment and multiple-organ failure caused by various acute triggering factors on the basis of chronic liver disease. Due to its severe condition, rapid progression, and high mortality, it has received increasing attention. Recent studies have shown that the pathogenesis of ACLF mainly includes direct injury and immune injury. In immune injury, cytotoxic T lymphocytes (CTLs), dendritic cells (DCs), and CD4+ T cells accumulate in the liver tissue, secrete a variety of proinflammatory cytokines and chemokines, and recruit more immune cells to the liver, resulting in immune damage to the liver tissue, massive hepatocyte necrosis, and liver failure, but the key molecules and signaling pathways remain unclear. The “danger hypothesis” holds that in addition to the need for antigens, damage-associated molecular patterns (DAMPs) also play a very important role in the occurrence of the immune response, and this hypothesis is related to the pathogenesis of ACLF. Here, the research status and development trend of ACLF, as well as the mechanism of action and research progress on various DAMPs in ACLF, are summarized to identify biomarkers that can predict the occurrence and development of diseases or the prognosis of patients at an early stage.

21 February 2017 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
JXJun-Chi Xu
Jun-Chi Xu
ZLZe‐Yi Li
Ze‐Yi Li
XCXin‐Nian Chen
Xin‐Nian Chen
CSCui‐Lin Shi
Cui‐Lin Shi
MWMei‐Ying Wu
Mei‐Ying Wu
PXPing Xu
Ping Xu
Objective: Tuberculosis (TB)‐interferon gamma release assay (IGRA) test has the characteristics of short time, high specificity, and high sensitivity, but it lacks the correlation research between TB‐IGRA test results and body's immune cells, disease progression and prognosis, which is explored in this study.Design: A retrospective study was carried out on positive TB‐IGRA patients who were infected with TB and diagnosed at our hospital from January 2014 to June 2015. The TB‐IGRA, routine blood test, T‐cell subgroup data were collected for statistical analysis.Results: TB‐IGRA results were in positive proportion to the lymphocytes, CD4+T cells and CD4+CD28+T cells, whereas negative to the Treg cells. Patient with unilateral pulmonary lesion had higher TB‐IGRA than those with bilateral pulmonary lesions. After the stimulation of TB‐specific antigen, the proportion of CD4+IFN‐γ+ and CD8+IFN‐γ+T Tcells were both increased and the CD4+IFN‐γ+T had positive correlation with the value of TB‐IGRA.Conclusions: IFN‐γ was tested with TB‐IGRA in patients with TB by the specific TB T cells and correlated with the lymphocytes, while the lymphocytes also closely related to the host's anti‐TB immunity and disease outcome. Hence the result of TB‐IGRA could reflect the specific anti‐TB immunity ability of the host, disease progression and prognosis. This study further expands the application scope of TB‐IGRA technology in the diagnosis of TB and lays a foundation for clinical practice to understand the immunity state of the patients with TB and the application of auxiliary clinical immunity regulators.

30 July 2022 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
XYXin Yu
Xin Yu
YLYao Lin
Yao Lin
HCHui Chen
Hui Chen
MWMin-Juan Wu
Min-Juan Wu
LHLi-Na Huang
Li-Na Huang
JXJun-Chi Xu
Jun-Chi Xu
Background: Regulatory T cells (Treg cells) in the peripheral blood of patients with pulmonary tuberculosis (PTB) may be closely related to the progression of PTB. In this study, the distribution characteristics and clinical importance of CD8+CD28− Treg cells in patients with tuberculosis were systematically analyzed, and the role and importance of CD8+CD28− Treg cells in influencing the immune response and progression of tuberculosis were discussed, which will provide immunological indices and reference values for the clinical diagnosis of tuberculosis. Methods: Flow cytometry, sputum smears and computed tomography imaging were used to analyze the distribution characteristics of CD8+CD28− Treg cells in the peripheral blood of patients with PTB and the correlation between CD8+CD28−Treg cells and clinical and immune indices. Results: The percentages of CD4+CD25high and CD8+CD28− Treg cells in the peripheral blood of patients with PTB were significantly higher than those in the healthy control (HC) group. Further analysis showed that the percentage of CD4+CD25highTreg cells in the Stage II group was significantly higher than that in the HC group. The percentages of CD4+CD25high and CD8+CD28− Treg cells increased significantly in patients in the Stage II group. The proportion of CD8+CD28− Treg cells was directly proportional to the degree of positivity in sputum smears, while CD4+CD25highTreg cells did not exhibit this trend. The correlations between the percentage of CD4+CD25high and CD8+CD28− Treg cells and the percentage of lymphocyte subsets were examined. The percentage of CD8+CD28− Treg cells was negatively correlated with the percentage of CD4+T cells and positively correlated with the CD8+T cell percentage in the HC and PTB groups. The percentage of CD4 + CD25highTreg cells was positively correlated with the percentage of CD4+T cells only in the PTB group. Conclusions: This study was the first to show that the proportion of CD8+CD28− Treg cells in the peripheral blood of patients with PTB was significantly increased, and the increase in CD8+CD28− Treg cells was related to the progression of PTB, which may affect the proportion of immune cell subsets by inhibiting the immune response, resulting in the progression of PTB.

22 November 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LMLiling Ma
Liling Ma
QHQingzhen Han
Qingzhen Han
LCLongji Cheng
Longji Cheng
HSHuafeng Song
Huafeng Song
RQRui Qiang
Rui Qiang
JXJun-Chi Xu
Jun-Chi Xu
Introduction: Mitochondrial membrane potential (MMP) and mitochondrial mass (MM) affect mitochondrial function and lymphocyte activation, but few studies on HBV infection exist. This study aimed to investigate the regulatory mechanism of mitochondrial dysfunction during HBV infection and its clinical significance by analyzing the alterations of MM and MMPlow in peripheral blood immune cells.Methods: The study enrolled 90 participants, including healthy volunteers(HC) and patients with HBV infection, HBV patients were divided into chronic hepatitis B patients (CHB) and liver cirrhosis (LC) according to the study, and CHB was also divided into an inflammation group and a non-inflammation group. Flow cytometry was used to analyze the changes of MM and MMPlow in peripheral blood immune cells. These analyses were correlated with the presence of CHB and LC and indexes related to liver inflammation.Results: The study revealed significant variations in the percentage of MMPlow and MM of CD8+T cells associated with the progression of the disease. The MMPlow percentage of CD8+T cells in the LC group exhibited a notable decrease compared to the HC group and CHB groups. Moreover, MMPlow of CD8+T cells demonstrated potential in distinguishing CHB and LC (AUC=0.7341, P=0.0032). Furthermore, in exploring the link between mitochondrial function of immune cells and liver inflammation, the study found a negative correlation between the MMPlow ratio of CD4+T and CD8+T cells and AST (p=0.0039 and P=0.0070, r=-0.4405 and r=-0.4146), while the MM of CD8+T cells displayed a positive correlation with AST (p=0.0013, r=0.4865). In CHB patients with normal ALT but liver inflammation detected on B-scan ultrasonography, a significant decrease was observed in the MMPlow percentage of CD8+T (66.13 ± 14.27), CD56+NK(57.77 ± 17.40) and CD4-CD8-T (61.98 ± 15.98) cells. Furthermore, it was also found that the percentage of MMPlow in CD4-CD8-T cells could serve as an indicator for early liver inflammation and injury (AUC=0.8408, P=0.0052).Discussion: In this study, we conducted a systematic analysis of the percentage of lymphocyte MMPlow and MM in various stages of HBV infection. Our findings revealed a correlation between MMPlow and MM and early liver inflammation, as well as the progression of the infection. This study marked the first demonstration of the clinical diagnostic value of MMPlow and MM in HBV infection. Furthermore, this was the first study to discuss the mitochondria of lymphocytes and liver inflammation in HBV infection. It enhanced the understanding of the role of T cells in liver inflammation, and elucidated potential markers for the early detection of liver injury and clinical cirrhosis.

1 April 2023 in Microbial Pathogenesis
Verified
Journal Article
Closed access
JCJie Chen
Jie Chen
JXJun-Chi Xu
Jun-Chi Xu
YNYayan Niu
Yayan Niu
LYLin Yao
Lin Yao
XLXuanmiao Liu
Xuanmiao Liu
PXPing Xu
Ping Xu

31 December 2022 in BMC Immunology
Verified
Journal Article
Open access
PDF file
XYXin Yu
Xin Yu
LHLi-Na Huang
Li-Na Huang
JXJun-Chi Xu
Jun-Chi Xu
YSYi-Yan Song
Yi-Yan Song
HCHui Chen
Hui Chen
YZYEHAN ZHU
YEHAN ZHU
Background: Tuberculosis infection is a major complication of silicosis, but there is no study on whether silicosis can affect the sensitivity of QuantiFERON-TB Gold In-Tube (QFT-GIT) assays. This study will analyze the relationship between silicosis and QFT-GIT, determine the main factor of the QFT-GIT sensitivity decrease in silicosis and explore the methods to increase the sensitivity. Methods: Silicosis patients with positive tubercle bacillus cultures were collected. The QFT-GIT, flow cytometry and blocking antibodies were used. Results: The sensitivity of QFT-GIT in silicosis patients (58.46%) was significantly decreased and the expression of PD-1 on T cells and CD56+NK cells in pulmonary tuberculosis combined with silicosis were higher than normal tuberculosis patients and silicosis only patients. Further analysis found that the ratio of PD-1+CD4+T and IFN-γwere negatively correlated and blockaded the PD-1 pathway with antibodies can restore the sensitivity of QFT-GIT in silicosis. Conclusions: This is the first study to analyze the relationship between immune exhaustion and QFT-GIT in silicosis and found that the sensitivity of QFT-GIT was decreased by the expression of PD-1 on lymphocytes. Antibody blocking experiments increased the expression of IFN-γ and provided a new method to improve the sensitivity of QFT in silicosis. The study also found that silicosis can increase PD-1 expression. As PD-1 functions in infectious diseases, it will promote immune exhaustion in silicosis and lead to tuberculosis from latent to active infection. The study provided theoretical evidence for the diagnosis and immunotherapy of silicosis complications, and it has great value in clinical diagnostics and treatment.